Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recruitment for Remote Decentralized Studies in Parkinson's Disease.
Myers TL, Augustine EF, Baloga E, Daeschler M, Cannon P, Rowbotham H, Chanoff E; 23andMe Research Team; Jensen-Roberts S, Soto J, Holloway RG, Marras C, Tanner CM, Dorsey ER, Schneider RB. Myers TL, et al. Among authors: holloway rg. J Parkinsons Dis. 2022;12(1):371-380. doi: 10.3233/JPD-212935. J Parkinsons Dis. 2022. PMID: 34744053 Free PMC article.
A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson's Disease: Study Protocol and Design.
Schneider RB, Myers TL, Rowbotham HM, Luff MK, Amodeo K, Sharma S, Wilson R, Jensen-Roberts S, Auinger P, McDermott MP, Alcalay RN, Biglan K, Kinel D, Tanner C, Winter-Evans R, Augustine EF, Cannon P; 23andMe Research Team; Holloway RG, Dorsey ER. Schneider RB, et al. Among authors: holloway rg. J Parkinsons Dis. 2020;10(3):1195-1207. doi: 10.3233/JPD-202019. J Parkinsons Dis. 2020. PMID: 32568109 Free PMC article.
A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson Disease: Baseline Results.
Jensen-Roberts S, Myers TL, Auinger P, Cannon P, Rowbotham HM, Coker D, Chanoff E, Soto J, Pawlik M, Amodeo K, Sharma S, Valdovinos B, Wilson R, Sarkar A, McDermott MP, Alcalay RN, Biglan K, Kinel D, Tanner C, Winter-Evans R, Augustine EF, Holloway RG, Dorsey ER, Schneider RB. Jensen-Roberts S, et al. Among authors: holloway rg. Neurol Genet. 2022 Aug 11;8(5):e200008. doi: 10.1212/NXG.0000000000200008. eCollection 2022 Oct. Neurol Genet. 2022. PMID: 35966918 Free PMC article.
Biomarkers in Parkinson's disease.
Dorsey ER, Holloway RG, Ravina BM. Dorsey ER, et al. Among authors: holloway rg. Expert Rev Neurother. 2006 Jun;6(6):823-31. doi: 10.1586/14737175.6.6.823. Expert Rev Neurother. 2006. PMID: 16784406 Review.
Symptom burden among individuals with Parkinson disease: A national survey.
Tarolli CG, Zimmerman GA, Auinger P, McIntosh S, Horowitz RK, Kluger BM, Dorsey ER, Holloway RG. Tarolli CG, et al. Among authors: holloway rg. Neurol Clin Pract. 2020 Feb;10(1):65-72. doi: 10.1212/CPJ.0000000000000746. Epub 2019 Nov 18. Neurol Clin Pract. 2020. PMID: 32190422 Free PMC article.
Quantitative risk-benefit analysis of natalizumab.
Thompson JP, Noyes K, Dorsey ER, Schwid SR, Holloway RG. Thompson JP, et al. Among authors: holloway rg. Neurology. 2008 Jul 29;71(5):357-64. doi: 10.1212/01.wnl.0000319648.65173.7a. Neurology. 2008. PMID: 18663181 Free PMC article.
224 results